Sandbox: jss: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by the same user not shown)
Line 4: Line 4:




{{Family tree/start}}
{| border="1"
{{Family tree | | | | | | | | | | | | | | A01 | | | | | | | | | | | |A01=Potassium >5.1meq/L}}
|+ The table's caption
{{Family tree | | | | | | | | | | | | | | |!| | | | | | | | | | | | }}
! Differentiating features !! Leukemia !! Leukemoid reaction
{{Family tree | | | | | | | | | | | | | | B01 | | | | | | | | | | | B01= ECG }}
|-
{{Family tree | | | | | | | | | | | | |,|-|^|-|.| | | | | | | | | | }}
! Causes
{{Family tree | | | | | | | | | | | | C01 | | C02 | | | | | | | | | C01=If no changes,rule out pseudohyperkalemia| C02= If changes present then start urgent treatment}}
| Carcinogens || Infectious agents, biologically active substances and
{{Family tree | | | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | | | | |}}
products of tissue destruction
{{Family tree | | | | | | | D01 | | | | | | | D02 |D01=Urine sodium <25 meq/L|D02=urine sodium >25 meq/L }}
|-
{{Family tree | | | | | | | |!| | | |,|-|-|-|-|^|-|-|-|-|.| | | | | }}
! Pathogenesis
{{Family tree | | | | | | | E01 | | E02 | | | | | | | | E03 | | | | | | | E01=ARF<br>CKD<br>Heart failure<br>Volume depletion|E02=Decreased K+secretion(Urine K+<20meq/L|E03=Transcellular shift(measure serum osmolarity and pH) }}
| The transformation of normal haematopoietic
{{familytree  | | | | | | |,|-|-|-|-|^|-|-|.| | | | | | |!| | | | | | | | }}
cells to a tumor
{{Family tree | | | | | | F01 | | | | | | F02 | | | | | F03 | | | | | | F01=Low aldosterone(TTG<3)|F02=Normal aldosterone(TTG>7)|F03=Diabetic ketoacidosis<br>Metabolic acidosis}}
| Activation of normal hematopoiesis and exit of immature leukocytes
{{Family tree | | | | |,|-|^|-|.| | | | | |!| | | | | | | | | | | }}
into the bloodstream.
{{Family tree | | | | G01 | | G02 | | | | G03 | | | | | | | | | | G01=Low renin|G02=Normal renin|G03=Tissue breakdown<br>Pseudohypoaldosternism type 1 and type 2<br>Type 1 RTA }}
|-
{{Family tree | | | | |!| | | |!| | | | | | | | | | | | }}
! Duration
{{Family tree | | | | H01 | | H02 | | | | | | | | | H01=Interstital nephritis<br>Obstructive uropathies<br>Diabetic nephropathy<br>ACE inhibitors,Angiotensin 2 receptors|H02=Primary hypoaldosteronism<br>Congenital adrenal hyperplasia<br>Aldosterone receptor antagonists<br>RTA type 4
| Chronic
}}
| Temporary and reversible
|-
! Genetic level
| Defect
| No defect
|-
! Splenomegaly
| Present
| Not present
|-
! Peripheral blood
| Immature cells, pancytopenia
| Mature and immature granulocytes with left shift
|-
! Bone marrow
| Increase in blasts and immature cells
| Myeloid hyperplasia and normal morphology
|-
! LAP score
| Low
| High
|-
! Toxic granules
(suggestive of infection)
| Absent
| Present
|-
! Dohle inclusion bodies
| Absent
| Present

Latest revision as of 14:25, 9 October 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


The table's caption
Differentiating features Leukemia Leukemoid reaction
Causes Carcinogens Infectious agents, biologically active substances and

products of tissue destruction

Pathogenesis The transformation of normal haematopoietic

cells to a tumor

Activation of normal hematopoiesis and exit of immature leukocytes

into the bloodstream.

Duration Chronic Temporary and reversible
Genetic level Defect No defect
Splenomegaly Present Not present
Peripheral blood Immature cells, pancytopenia Mature and immature granulocytes with left shift
Bone marrow Increase in blasts and immature cells Myeloid hyperplasia and normal morphology
LAP score Low High
Toxic granules
(suggestive of infection)
Absent Present
Dohle inclusion bodies Absent Present